Anmeldung erfolgt in Kürze...
Details werden geladen...
HER2 Tyrosine Kinase Inhibitors: Class Deep Dive
Five HER2 kinase inhibitors now span breast, lung, and colorectal cancer. Trial data and comment from Erika Hamilton, MD, show how labels, safety, and interactions differ.
Ähnliche Seiten
Managing Immune Checkpoint Inhibitor Colitis
https://www.medscape.com/viewarticle/managing-immune-checkpoint-inhibitor-colitis-guide-2026a10012o4HER2-Directed Antibodies: 14 Products Compared
https://www.medscape.com/c99/p10/after-28-years-trastuzumab-has-competition-head-head-loss-2026a10016qkNew Cancer Drugs: Can Care Keep Up With Innovation?
https://www.medscape.com/viewarticle/new-cancer-drugs-can-care-keep-innovation-2026a10010g7FDA Okays Tucatinib for HER2+ Breast Cancer Maintenance
https://www.medscape.com/viewarticle/fda-okays-tucatinib-her2-positive-breast-cancer-maintenance-2026a10011ngFDA Approves Dostarlimab for Rectal Cancer
https://www.medscape.com/viewarticle/fda-approves-dostarlimab-rectal-cancer-2026a10013c7